Steris (STE) Enterprise Value Growth (1y) (2018 - 2026)
Steris (STE) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Steris | 21.53 Bn | 21.09 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -167.42% |
| Dec 31, 2025 | -187.46% |
| Sep 30, 2025 | -96.94% |
| Jun 30, 2025 | -46.21% |
| Mar 31, 2025 | 17.81% |
| Dec 31, 2024 | 21.95% |
| Sep 30, 2024 | 23.41% |
| Jun 30, 2024 | 8.08% |
| Mar 31, 2024 | 2.32% |
| Dec 31, 2023 | 26.60% |
| Sep 30, 2023 | 17.91% |
| Jun 30, 2023 | 34.85% |
| Mar 31, 2023 | 40.95% |
| Dec 31, 2022 | 28.11% |
| Sep 30, 2022 | 34.03% |
| Jun 30, 2022 | 41.88% |
| Mar 31, 2022 | -59.98% |
| Dec 31, 2021 | -43.64% |
| Sep 30, 2021 | -26.12% |
| Jun 30, 2021 | -117.95% |